Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.55 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.51 |
| ▸ | CHRNA5 | P30532 | 2/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ATR | Q13535 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12138051 | 0.88 | ADORA2A (0.53) | ADORA2AADORA1CHRNB2CHRNA5CHRNA4 | |
| SCHEMBL12135555 | 0.82 | ADORA2A (0.58) | ADORA2AADORA1CHRNB2CHRNA5CHRNA4 | |
| SCHEMBL12137467 | 0.81 | ADORA1 (0.59) | ADORA2AADORA1KDM4ENEK1ALDH1A1 | |
| SCHEMBL12137698 | 0.80 | ADORA2A (0.60) | ADORA2AADORA1KDM4EHSD17B10RXFP1 | |
| SCHEMBL12137688 | 0.78 | PIK3CG (0.55) | ADORA2AADORA1KDM4ECYP11B2CYP17A1 | |
| SCHEMBL12137470 | 0.78 | CYP1A2 (0.52) | ADORA2AADORA1CYP11B2CYP11B1ATR | |
| SCHEMBL12137903 | 0.77 | ADORA2A (0.50) | ADORA2AADORA1KDM4EHSD17B10HTT | |
| SCHEMBL29809001 | 0.76 | CYP11B2 (0.71) | CHRNB2CHRNA5CHRNA4CYP11B2CYP17A1 | |
| SCHEMBL13537172 | 0.76 | CYP11B2 (0.71) | CHRNB2CHRNA5CHRNA4CYP11B2CYP17A1 | |
| SCHEMBL27612525 | 0.76 | ADORA2A (0.63) | ADORA2AADORA1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110281838-A1 | 5-ALKYNYL-PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110281838-A1 | 5-ALKYNYL-PYRIMIDINES | MKI67, CCNA1, CCNT1 | ADORA2A 314/4885ADORA1 87/4885CHRNB2 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.